• Price (USD)159.52
  • Today's Change-31.64 / -16.55%
  • Shares traded2.46m
  • 1 Year change+27.74%
  • Beta1.0511
Data delayed at least 15 minutes, as of Oct 28 2021 20:27 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade, Alnylam Pharmaceuticals Inc (ALNY:NSQ) traded at 159.52, 33.72% above the 52 week low of 119.29 set on Oct 30, 2020.
52-week range
119.29Oct 30 2020212.00Oct 14 2021
Markit short selling activity
Previous close191.16
Average volume399.46k
Shares outstanding118.85m
Free float118.09m
P/E (TTM)--
Market cap22.72bn USD
EPS (TTM)-7.60
Data delayed at least 15 minutes, as of Oct 28 2021 20:27 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.